Maine Molecular Quality Controls Inc now offers its INTROL™ line of quality controls for molecular diagnostic testing of cystic fibrosis. The CF Panel I control contains 42 mutations and polymorphisms, including those required by the ACMG/ACOG recommended test panel. The company’s processes also have produced INTROL™ products for thrombotic-risk testing.
INTROL™ products feature rare genotypes and multiple mutations that are contained in single samples, enabling affordable monitoring of all test analytes. INTROL™ products are extractable by clinical methods and monitor the extraction step as required by regulations and best practice.
Maine Molecular Quality Controls Inc
(207) 885-1072; www.mmqci.com
